Canada’s prescription opioid epidemic grows despite tamperproof pills

  title={Canada’s prescription opioid epidemic grows despite tamperproof pills},
  author={O. Dyer},
  journal={BMJ : British Medical Journal},
  • O. Dyer
  • Published 2015
  • Medicine
  • BMJ : British Medical Journal
“Weak” doctors who cannot say no to their patients are driving Canada’s prescription opioid epidemic, the Canadian Medical Association’s annual general council heard this week, as new research showed that the mortality risk from chronic high doses may have been badly underestimated. OxyContin (oxycodone), the drug most closely associated with the rapid spread of opioid prescribing across North America, has been replaced with a tamperproof formula called OxyNEO. But in Canada, where provincial… Expand
An examination of opioid prescription for Medicare Part D patients among family practice prescribers.
The next step in policies to reduce prescription opioids will require systemic change, especially providing support for family practitioners in rural health care shortage areas, as well as monitoring extreme prescribers. Expand
At-a-glance - The local response to the Canadian opioid epidemic in the Kingston, Frontenac, and Lennox and Addington communities.
  • A. Bahji, Daenis Camiré
  • History, Medicine
  • Health promotion and chronic disease prevention in Canada : research, policy and practice
  • 2019
This article provides a description of recent activities to address the local opioid crisis, a rationale for their adoption and the context in which they are being undertaken. Expand
The rural-urban gap: differences in injury characteristics.
The nature of injuries in rural settings differ from those in urban settings, and there is a need to evaluate current injury prevention efforts in rural setting with the aim to close the gap between rural and urban injury rates. Expand


Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study
Men are at higher risk than women for escalation to high-dose opioid therapy and death from opioid-related causes and both outcomes were more common than anticipated. Expand